Formulations for wound therapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9717821
SERIAL NO

14131012

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to novel formulations comprising a dry powder fibrin sealant comprised of a mixture of fibrinogen and/or thrombin, for use in the treatment of wounds or injuries, in particular for use as a topical hemostatic composition or for surgical intervention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MALLINCKRODT PHARMA IP TRADING D A CDAMASTOWN INDUSTRIAL ESTATE MULHUDDART DUBLIN 15

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Martyn, Glen Leicestershire, GB 11 98
Schutte, Eliane Utrecht, NL 4 61
Senderoff, Richard Edmonds, US 2 33
Zuckerman, Linda Seattle, US 6 108

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 1, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 1, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00